Systematic review / meta-analysis / 2019
Vitamin D supplementation was not associated with reduced major adverse cardiovascular events or all-cause mortality in a meta-analysis of 21 RCTs.
A meta-analysis of 21 randomized clinical trials evaluated the effect of long-term (≥1 year) vitamin D supplementation in 83,291 participants (41,669 receiving vitamin D, 41,622 receiving placebo). Vitamin D supplementation was not associated with reduced major adverse cardiovascular events (RR, 1.00; 95% CI, 0.95-1.06; P = .85) or all-cause mortality (RR, 0.97; 95% CI, 0.93-1.02; P = .23). No significant reductions were seen for myocardial infarction (RR, 1.00; 95% CI, 0.93-1.08), stroke (RR, 1.06; 95% CI, 0.98-1.15), or CVD mortality (RR, 0.98; 95% CI, 0.90-1.07). The abstract notes that only 4 trials prespecified CVD as a primary endpoint.
- Study type
- Meta-analysis of randomized clinical trials
- Who was studied
- 83,291 participants across 21 RCTs (mean age 65.8 years, 74.4% female)
- What was measured
- Major adverse cardiovascular events, myocardial infarction, stroke, CVD mortality, and all-cause mortality
THE PAPER
Vitamin D Supplementation and Cardiovascular Disease Risks in More Than 83 000 Individuals in 21 Randomized Clinical Trials: A Meta-analysis.
Barbarawi M, Kheiri B, Zayed Y, Barbarawi O, Dhillon H, Swaid B, Yelangi A, Sundus S, Bachuwa G, Alkotob ML, Manson JE. JAMA Cardiol, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.